The mRNA platform market holds significant opportunities, driven by advancements in LNP delivery systems, codon optimization, and synthetic biology tools like CRISPR-Cas9. These innovations support ...

CompanyOverview\|NASDAQ:MRNA] Moderna Inc. (NASDAQ: MRNA) is down 35% in 2025, making it one of the worst-performing stocks ...

At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options chain for the new August 15th contracts and identified one put and one call contract of particular interest.

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7% in the afternoon session after the FDA announced new ...

A San Diego biotech company is helping top research labs develop mRNA vaccines, including a vaccine for some types of cancer. Jaime Chambers reports. STORY: fox5sandiego.com ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

Dr Wiklund added that mRNA vaccines require cold chain storage, so aren’t ideal for use in more difficult locations. He explained: “For more permanent pathogens, for example, polio or measles ...

New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a ...

More than a billion people around the world suffer from mental disorders such as Alzheimer’s, Parkinson’s, ALS, Huntington’s, ...

New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a ...